Comprehensive Clinical Development, Inc.

St. Petersburg, Florida 33716

0 studies enrolling now · 9 studies all time

What they study most

Acute Treatment of Migraine, Depression, Diabetic Peripheral Neuropathic Pain, Major Depressive Disorder, Migraine, Post Herpetic Neuralgia, Post-Herpetic Neuralgia (PHN), Smoking Cessation, Type 2 Diabetes Mellitus

Studies at this site

• Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine — Completed
• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study — Stopped early
• Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia — Completed
• Smoking Cessation Study In Healthy Adolescent Smokers — Completed
• Diabetic Peripheral Neuropathic Pain (DPNP) — Completed
• Crossover Post-herpetic Neuralgia (PHN) — Completed
• Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression — Stopped early
• Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression — Completed
• Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus — Completed